The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Valneva SE(NASDAQ:VALN) 
Valneva SE is a French biotech company headquartered in Saint-Herblain, France, developing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden and Vienna, Austria, with other offices in France, Canada and the United States.
Website: https://valneva.com/
Founded: 2012
CEO: Thomas Lingelbach
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Share this website to your friends
Valneva SE Days Payable Outstanding ttm (DPO)
Valneva SE Days Receivable Outstanding ttm (DSO)
Valneva SE Days Inventory Outstanding ttm (DIO)
Valneva SE Op Cashflow Per Share ttm
Valneva SE Free Cashflow Per Share ttm
Valneva SE Cash Per Share ttm
Valneva SE P/S ratio ttm
Valneva SE (GAAP) P/E ratio ttm
Valneva SE P/B ratio ttm
No extra charts and metrics for this ticker.